Detalles de la búsqueda
1.
"Money was the problem": Caregivers' self-reported reasons for abandoning their children's cancer treatment in southwest Uganda.
Pediatr Blood Cancer
; 68(11): e29311, 2021 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-34459106
2.
Outcomes of a clinical pathway for primary outpatient management of pediatric patients with low-risk febrile neutropenia.
Pediatr Blood Cancer
; 66(7): e27679, 2019 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-30916887
3.
Facial manifestations of Epstein-Barr virus-related lymphoproliferative disease in childhood acute lymphoblastic leukemia in remission: Two atypical presentations.
Pediatr Blood Cancer
; 63(11): 2042-5, 2016 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-27392033
4.
Impact of persistent minimal residual disease post-consolidation therapy in children and adolescents with advanced Burkitt leukaemia: a Children's Oncology Group Pilot Study Report.
Br J Haematol
; 170(3): 367-71, 2015 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-25858645
5.
Rituximab with chemotherapy in children and adolescents with central nervous system and/or bone marrow-positive Burkitt lymphoma/leukaemia: a Children's Oncology Group Report.
Br J Haematol
; 167(3): 394-401, 2014 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-25066629
6.
Excellent outcomes in children and adolescents with CNS+ Burkitt lymphoma or other mature B-NHL using only intrathecal and systemic chemoimmunotherapy: results from FAB/LMB96 and COG ANHL01P1.
Br J Haematol
; 185(2): 374-377, 2019 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-30117142
7.
Pediatric-type nodal follicular lymphoma: an indolent clonal proliferation in children and adults with high proliferation index and no BCL2 rearrangement.
Blood
; 120(12): 2395-404, 2012 Sep 20.
Artículo
en Inglés
| MEDLINE | ID: mdl-22855608
8.
Advanced stage anaplastic large cell lymphoma in children and adolescents: results of ANHL0131, a randomized phase III trial of APO versus a modified regimen with vinblastine: a report from the children's oncology group.
Pediatr Blood Cancer
; 61(12): 2236-42, 2014 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-25156886
9.
Disseminated lymphoblastic lymphoma in children and adolescents: results of the COG A5971 trial: a report from the Children's Oncology Group.
Br J Haematol
; 162(6): 792-801, 2013 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-23889312
10.
Hsp90 inhibition disrupts JAK-STAT signaling and leads to reductions in splenomegaly in patients with myeloproliferative neoplasms.
Haematologica
; 103(1): e5-e9, 2018 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-29051283
11.
Relapse after treatment of pediatric Hodgkin lymphoma: outcome and role of surveillance after end of therapy.
Pediatr Blood Cancer
; 60(9): 1458-63, 2013 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-23677874
12.
Phase II study of 2-chlorodeoxyadenosine plus idarubicin for children with acute myeloid leukaemia in first relapse: a paediatric oncology group study.
Br J Haematol
; 156(5): 649-55, 2012 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-22512017
13.
Prevalence and prognostic significance of KIT mutations in pediatric patients with core binding factor AML enrolled on serial pediatric cooperative trials for de novo AML.
Blood
; 115(12): 2372-9, 2010 Mar 25.
Artículo
en Inglés
| MEDLINE | ID: mdl-20056794
14.
Outcome of newly diagnosed children and adolescents with localized lymphoblastic lymphoma treated on Children's Oncology Group trial A5971: a report from the Children's Oncology Group.
Pediatr Blood Cancer
; 59(7): 1229-33, 2012 Dec 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-22488718
15.
Association between radiotherapy vs no radiotherapy based on early response to VAMP chemotherapy and survival among children with favorable-risk Hodgkin lymphoma.
JAMA
; 307(24): 2609-16, 2012 Jun 27.
Artículo
en Inglés
| MEDLINE | ID: mdl-22735430
16.
Phase I study of valspodar (PSC-833) with mitoxantrone and etoposide in refractory and relapsed pediatric acute leukemia: a report from the Children's Oncology Group.
Pediatr Blood Cancer
; 54(5): 694-702, 2010 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-20209646
17.
A study of rituximab and ifosfamide, carboplatin, and etoposide chemotherapy in children with recurrent/refractory B-cell (CD20+) non-Hodgkin lymphoma and mature B-cell acute lymphoblastic leukemia: a report from the Children's Oncology Group.
Pediatr Blood Cancer
; 52(2): 177-81, 2009 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-18816698
18.
Treatment of children with acute promyelocytic leukemia: results of the first North American Intergroup trial INT0129.
Pediatr Blood Cancer
; 53(6): 1005-10, 2009 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-19743516
19.
Disease site number was not prognostic in a low-risk Hodgkin lymphoma combined modality trial: revisiting PHC HOD90.
Blood Adv
; 7(21): 6665-6667, 2023 11 14.
Artículo
en Inglés
| MEDLINE | ID: mdl-37647596
20.
Using Physician-Level Emergency Department Utilization Reports to Address Avoidable Visits by Patients Managed by Pediatric Specialists.
Hosp Pediatr
; 7(11): 686-691, 2017 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-29055023